Tami John, MD, on the FDA Approvals of Exa-cel and Lovo-cel
The clinical associate professor at Stanford Medicine also discussed ongoing trends in sickle cell disease research.
Tami John, MD, on Assessing Red Blood Cell Function After Patients Receive Treatment for Sickle Cell Disease
The clinical associate professor at Stanford Medicine discussed new research on patients who have received HCT or gene therapy for SCD.